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The plasma amino acid pattern of uremic patients
diverges strikingly from that of normal subjects.
Several authors have reported low concentrations
of most essential amino acids (EAA) and high con-
centrations of some of the nonessential amino acids
(NEAA) [1—71.
The concentration of several free amino acids is
considerably higher in the cells than it is in the ex-
tracellular fluid [5, 8—101, and skeletal muscle is, by
far, the largest intracellular pool. We have pre-
viously reported [ill gross abnormalities in the free
amino acid pattern of muscle in severely uremic pa-
tients; concentrations of threonine, valine, tyro-
sine, and carnosine were low, and glycine:valine
and phenylalanine:tyrosine ratios were high. Some
of these changes might be attributable to protein
malnutrition or enhanced catabolism.
This is a report of the extracellular and intra-
cellular free amino acid patterns in uremic patients
treated only with protein-poor diet (18 g of protein/
day) or with the protein-poor diet supplemented
with EAA (a regimen shown to bring uremic pa-
tients into positive nitrogen balance) [111.
Methods
Sixteen patients with advanced chronic renal fail-
ure were studied, none of whom had been dialyzed.
The nature and purpose of the study was explained
to them before their voluntary consent was ob-
tained. The muscle biopsies, which constituted the
invasive part of the investigation, were approved by
the Ethical Committee of the Karolinska Institutet,
Stockholm.
Ten patients (Table 1) were admitted because of
symptoms of uremia, such as fatigue, nausea, and
vomiting. Eight (#1—8) had been treated with a con-
trolled protein-restricted diet (40 g of protein/day)
for 6 months to 3 yr, whereas two (#9—10) had been
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on an uncontrolled protein-restricted diet for about
a month. Serum albumin concentrations were low
in seven, and serum transferrin values were low in
six patients.
After admission, the patients were kept on a con-
trolled protein-poor diet containing about 18 g of
protein (2.6 g of nitrogen) and 2,500 kcal of energy
per day [12]. Any disturbances in fluid balance,
electrolytes, and acid-base balance, or hypo- or hy-
pertension were treated appropriately. Sodium bi-
carbonate, aluminum hydroxide (Uracid®, Astra
Läkemedel AB, Södertälje, Sweden), and calcium
gluconate or carbonate, Ito 4 g/day, were adminis-
tered to most patients; some received high does of
furosemide, 250 to 2,000 mg/day.
Muscle biopsies were performed after the pa-
tients had been on the protein-poor diet for 2 to 3
weeks, By then, their serum urea concentrations
had decreased and reached a steady state, and the
patients were in as optimal a general condition as
possible.
In six patients (#5—10), the nitrogen-poor diet
was supplemented with EAA administered in
coated tablets (Aminess, Astra Läkemedel AB,
Södertälje, Sweden). The dosage was 20 to 30 tab-
lets/day, providing 1.8 to 2.7 g of nitrogen per day.
Ten tablets contained 700mg of L-isoleucine, 1,100
mg of L-leucine, L-lysine acetate corresponding to
800 mg of L-lysine, 1,100mg of L-methionine, 1,100
mg of L-phenylalanine, 500 mg of L-threoflifle, 250
mg of L-tryptophan, 800 mg of L-valine (minimum
requirement according to Rose [13]), and 550 mg of
L-histidine. After amino acid supplementation for 1
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Table 1. Clinical data in 10 uremic patients treated with nitrogen-poor diet for 2 to 3 weeks and nitrogen-poor diet supplemented with
EAA (including histidine) orally for 1 to 2 weeksa
Patient
no. Sex
Serum Serum Serum
Age Diet Ccr creatinine urea albumin
yr Diagnosis g protein/day mi/mm pmoles/liter mmoles/liter giliter
Serum-
transferrin
gluier
Nitrogen-poor diet only
1 F 54 CON 20 2.4 1317 32.9 36 2.7
2 F 64 CGN 20 1.8 1519 40.9 30 1.8
3 F 55 CGN 20 3.7 1031 37.3 28 1.5
4 M 41 PCK 20 4.0 1320 35.2
Nitrogen-poor diet supplemented with EAA (including histidine orally) for 1—2 weeks
35 1.1
5 F 60 PCK 20 5.1 692 13.8
20 + EAA 773 8.2
38
37
1.7
6 M 66 CGN 20 3.0 1342 38.6
20 + EAA 1.8 1308 27.8
26
27
7 M 53 NS 20 751 27.8
20 EAA 619 25.7
32
40
1.5
1.3
8 M 61 NS 20 3.0 1547 22.5
20 + EAA 1750 18.6
36
32
2.4
9 F 63 PCI( 20 2.1 907 23.7
20 + EAA 800 17.1
34
35
1.6
1.6
10 F 64 CGN 20 3.3 954 26.4
20 + EAA 1.9 1007 27.8
37
39
2.2
2.3
a Abbreviations used are: Cr, endogenous creatinine clearance; EAA, essential amino acids; CGN, chronic glomerulonephritis; NS,
nephrosclerosis; PCK, polycystic kidney disease.
week (#5, 9) or 2 weeks (#6, 7, , 10), a second
muscle biopsy was performed.
Six patients (#11—16) were treated with the pro-
tein-poor diet and amino acid supplements at home
for more than 75 days and then were admitted for
investigation (Table 2). They were in good general
condition. Serum albumin concentrations were nor-
mal in all six patients, as were serum transferrin
concentrations in the four in whom it was deter-
mined. In four male patients (#11—14), nitrogen
balance studies were performed for 4 or 5 days.
Samples of muscle were taken from the quadri-
ceps femoris by percutaneous needle biopsy after
an overnight fast 114]. The wet biopsy material was
dissected carefully to remove all visible fat and con-
nective tissue; then it was divided into several por-
tions. One or two small portions (10 to 15 mg) were
used for determination of fat, fluid, and elec-
trolytes. Two larger portions (12 to 40 mg) were
used for measurement of intracellular free amino
acids in duplicate. Samples of plasma for fi'ee amino
acid determination were obtained at the time of
each muscle biopsy.
Our method for determination of free amino acids
in muscle and plasma has been described 10j, as
have also the calculation of extracellular and intra-
cellular water content and the intracellular amino
acid concentrations based on the chloride method
Table 2. Clinical data in six uremic patients treated with a nitrogen-poor diet (20 g proteinlday) plus EAA (including histidine) orally for
more than 10 weeksa
Patient
no. Sex
Age
yr Diagnosis
Days on
treatment
C(r
mi/mm
Serum
creatinine
pinoles/liter
Serum urea
rnmoles/liter
Serum
albumin
g/liter
Serum
transferrin
g/liter
Corrected
nitrogen-balance
giday
II M 20 CGN 160 3.1 2077 36.4 38 — 0
12 M 51 PCK 112 4.2 1503 44.2 40 2.4 —1.2
13 M 59 CGN 80 5.1 1370 32.1 37 — —0.2
14 M 67 CON 264 7.8 698 27.8 39 2.1 —0.7
15 F 42 CON 72 8,2 707 16.8 38 3.8 —
16 M 77 CPN 155 — 522 18.9 43 2.4 +0.5
a Abbreviations used are: CON, chronic glomerulonephritis; CPN, chronic pyelonephritis; PCK, polycystic kidney disease; Cç5,
endogenous creatinine clearance; EAA, essential amino acids.
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Table 3. Concentrations (mmoles/liter) of essential amino acids in plasma and the ratios of glycine/valine (GLY/VAL) and
phenylalanine/tyrosine (PHE/TYR), respectively
.Amino
acids
-
N
Healthy subjects
—
Mean SEM
Uremic patients on nitrogen-poor dieta
I
2—3 weeks
N
II
1—2 weeks
Mean SEM
III
3 months
N
-_________________
Mean SEM
—
N Mean SEM
Threonine
Valine
Isoleucine
Leucine
Phenylalanine
Methionine
Lysine
37
33
30
31
34
36
32
0.144 0.005
0.217 0.007
0.059 0.001
0.119 0.004
0.052 0.001
0.02 1 0.001
0.182 0.005
10
10
10
10
10
10
10
0.113 0.016-
0.109 0.011---
0.043 0.005
0.072 0.007-
0.054 0.004
0.034 0.005
0.177 0.020
6
6
6
6
6
6
6
0.146 0.024
0.127 O.017
0.049 0.003
0.072 0.004
0.049 0.003
0.026 0.003k
0.186 0.010
6
6
6
6
6
6
6
0.194 0.0l2
0.162 0.015
0.054 0.005
0.085 0.010
0.058 0.006
0.034 0.0O4
0.173 0.017
GLY/VAL
PHEITYR
13
13
1.02 0.037
0.998 0.036
10
10
3.29 0.49'
0.985 0.150
6
6
3.04 0.474
0.664 0.092
6
6
2.29 0.26
0.833 0.195
a I (nitrogen-poor diet), 11 (nitrogen-poor diet + EAA for I to 2 weeks), and III (nitrogen-poor diet + EAA for 3 months) were
statistically compared with the normal material. The statistically significant differences between I (nitrogen-poor diet) and II (nitrogen-
poor diet + EAA for ito 2 weeks) and between I and III (nitrogen-poor diet +EAA for 3 months) are given in the text. (EAA is essential
amino acids plus histidine.)
Plus (+) or minus (—) indicates high or low significance, respectively, with + = 0.01 > P < 0.05; ++ = 0.001 > P < 0.01; and
= P <0.001.
[10, 15, 161. Histidine, which is an EAA in severe
uremia [17—191, was combined with the NEAA to
conform with other reported data in this field.
Results
Uremic patients treated with nitrogen-poor diets (18 g of
protein/day)
Plasma (Tables 3 and 4). The concentrations of
the following EAA were low: threonine, valine, iso-
leucine, and leucine; by constrast, methionine was
high. The concentrations of the following NEAA
were high: taurine, aspartate, glutamine, proline,
glycine, and citrulline. The concentrations of other
NEAA were normal. The ratio of glycine:valine
was high.
Muscle (Tables 5 and 6). The concentrations of
threonine and valine were low, as were the concen-
trations of the dipeptide carnosine. Taurine, aspar-
tate, glutamine, glycine, and alanine concentrations
were high, as were 1-methyihistidine.
Patients on protein-poor diets supplemented with EAA
for I to 2 iveeks
Plasma (Tables 3 and 4). The concentration of
threonine normalized; those of taurine and aspar-
tate decreased and did not differ significantly from
those of healthy subjects. The concentrations of
alanine, tyrosine, and arginine were significantly
higher than they were in healthy subjects, whereas
the level of glutamic acid was significantly lower.
Muscle (Tables 5 and 6). The mean concentration
of valine was not significantly different from nor-
mal, but two patients had low concentrations. The
mean concentration of threonine was higher than it
was after nitrogen-poor diet only, but it was lower
than normal. The concentrations of tyrosine and
ornithine were significantly higher than normal.
In comparison with the nitrogen-poor diet alone,
the supplementation of the diet with EAA for 1 to 2
weeks did not result in any statistically significant
change of the amino acid concentrations in plasma
or muscle.
The effect of long-term (> 10 weeks) supplementation
with EAA
The mean nitrogen balance corrected for changes
in total body urea was slightly negative (— 0.32
0.29 g of nitrogen per day). The balance study was
performed after more than 10 weeks of supplemen-
tation and was conducted for 4 to 5 days.
Plasma (Tables 3 and 4). In comparison with the
nitrogen-poor diet alone, supplementation with
EAA resulted in statistically significant increases in
the concentrations of threonine (P <.0.01) and Va-
line P < 0.05); threonine and methionine were sig-
nificantly higher than normal, whereas valine was
lower than normal.
Muscle (Tables 5 and 6). The mean concentration
of threonine was higher than it was in patients on
the nitrogen-poor diet only, but it was lower than
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Table 4. Concentrations (mmoles/liter) of nonessential amino acids in plasma
Uremic patients on nitrogen-poor dieta
I 11 111
Amino
acids
Healthy subjects 2—3 weeks
N
1—2 weeks
--
Mean SEM
3 months
N Mean SEM N Mean SEM N Mean SEM
Taurine 34 0.076 0.005 10 0.120 0.016 6 0.091 0.010 6 0.093 0.017
Asparatate 37 0.010 0.001 10 0.032 0.007 6 0.016 0.005 6 0.018 0.004k
Serine 36 0.199 0.003 10 0.117 0.015 6 0.105 0.010 5 0.101 0.015
Asparagine 37 0.052 0.002 10 0.055 0.005 6 0.051 0.005 6 0.061 0.0060.038kGlutamine 38 0.579 0.015 10 0.761 0.087 6 0.795 0.043 6 0.686
Glutamic acid 34 0.050 0.004 10 0.043 0.017 6 0.020 0.005 6 0.026 0.005-
Proline 41 0.174 0.007 10 0.224 O.O22 6 0.183 0.018 6 0.217 0.026k
Citrulline 35 0.028 0.001 10 0.091 0.013 6 0.101 0.007 6 0.122 0.016
Glycine 40 0.222 0.008 10 0.346 0.050 6 0.373 0.047 6 0.355 0.035
Alanine 38 0.322 0.015 10 0.349 0.044 6 0.417 0.055 6 0.488 0.048
Tyrosine 34 0.052 0.002 10 0.062 0.008 6 0.081 0.008 6 0.086 0.0l6
Ornitine 39 0.072 0.004 10 0.074 0.009 6 0,074 0.006 6 0.069
Histidine 33 0.079 0.002 10 0.087 0.008 6 0.099 0.009 6 0.077 0.006
1-Methyl-histidine 6 0.003 0.001 7 0.039 0,015F++ 5 0.025 0.005 4 0.017 0.009
3-Methyl-histidine 13 0.004 0.001 10 0.053 0.010k 6 0.044 0.005 6 0.053
Arginine 37 0.078 0.003 10 0.085 0.012 6 0.099 0.007k 6 0.100
I (nitrogen-poor diet), 11 (nitrogen-poor diet + EAA for I to 2 weeks), and Ill (nitrogen-poor diet + EAA for 3 months) were
statistically compared with the normal material. The statistically significant difference between I (nitrogen-poor diet) and II (nitrogen-
poor diet + EAA for Ito 2 weeks) and between I and III (nitrogen-poor diet + EAA for 3 months) are given in the text. (EAA is essential
amino acids plus histidine.)
b Plus(+) or minus (—) indicates high or low significance, respectively, with + 0.01 > P < 0.05; il 0.001 > P <0.01; and = P
<0.001.
normal (P < 0.05); valine was not significantly low-
er than normal, but three of six patients had values
which were below normal. The concentration of
phenylalanine was lower than normal, and tyrosine
was more markedly reduced, resulting in a high
phenylalanine:tyrosine ratio. High concentrations
of lysine, ornithine, histidine, and arginine was ob-
served in muscle in the presence of normal plasma
lysine, ornithine, histidine, and normal or slightly
increased plasma concentrations of arginine. The
mean concentrations of glycine and glutamine were
normal in this group; aspartate was high, and carno-
sine was low.
Discussion
In patients treated with an 18-g protein diet, our
findings are similar to earlier results obtained in a
mixed population of non-dialyzed uremic patients
on either a 40-g protein diet or a free protein intake
[11]. In both groups, the intracellular concentra-
tions of valine, threonine, and carnosine were low;
the concentrations of some NEAA were high. The
18-g protein diet alone seems inadequate to main-
tain nitrogen balance in uremic patients, presum-
ably because it does not fulfill the minimum require-
ments of some of the EAA, e.g., phenylalanine,
methionine, and tryptophan [20]. The period of
treatment with only l8-g protein diet, however, may
have been too short to permit the amino acid in-
adequacies to express themselves in the form of re-
duced intracellular amino acid pools.
After supplementation of the diet with an excess
of EAA for I to 2 weeks, there was a tendency to-
ward normalization of threonine and valine concen-
trations in muscle (these are the two amino acids
generally found to be low in the intracellular pool in
all categories of uremic patients). Again, the time of
treatment may have been too short to affect the in-
tracellular amino acid pools to any larger extent.
The intracellular deficiencies of valine and threo-
nine persisted after more than 3 months of treat-
ment, in spite of the total intake being three to four
times higher than that for minimum requirements
1131. We had concluded earlier that low concentra-
tions of valine and threonine are typical sequelae of
severe uremia [11]. Present indications are that the
low intracellular concentrations of these amino
acids are not corrected by supplementation with
EAA, including two to three times increase in in-
take of valine and threonine. The low intracellular
concentration of threonine after supplementation
with amino acids appeared in the presence of a
plasma concentration which was significantly high-
er than normal. Under these conditions, the plasma
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Table 5. Intracellular concentrations (mmoles/liter intracellular water) of EAA in muscle and the ratios of glycine/valine (GLY/VAL)
and phenylalanine/tyrosine (PHE/TYR), respectively
Uremic patients on nitrogen-poor dietLt
I II III
.Amino
acids
Healthy subjects 2—3 weeks 1—2 weeks 3 months
-___________________
N Mean SEM N Mean sari N Mean SEM N Mean SEM
Threonine 29 0.956 0.035 10 0.570 0.068 6 0.715 0.104- 6 0.773 0.064
Valine 26 0.289 0.022 10 0.168 0.024 6 0.234 0.057 6 0.198 0.034
Isoleuciiie 27 0.100 0.013 10 0.068 0.013 6 0.065 0.012 6 0.076 0.008
Leucine 26 0.150 0.011 8 0.112 0.014 6 0.118 0.014 6 0.144 0.019
Phenylalanine 24 0.073 0.004 9 0.103 0.038 6 0.065 0.010 6 0.049 0.008
Methionine II 0.050 0.009 10 0.039 0.005 6 0.045 0.014 6 0.043 0.005
Lysine 25 1.092 0.047 10 1.210 0.214 6 1.154 0.159 6 1.573 0.l55
GLY/VAL 8 4.26 0.557 10 14.38 1.62 5 13.29 1.872 6 9.37 l.71
PHE/TYR 9 0.801 0.089 6 0.75 0.117 5 0.45 0.131 5 1.45 0.49
I (nitrogen-poor diet), II (nitrogen-poor diet + EAA for 1 to 2 weeks), and III (nitrogen-poor diet + EAA. for 3 months) were
statistically compared with the normal material. The statistically significant differences between t and II, and between I and III are given
in the text. (EAA is essential amino acids plus histidine.)
Plus (+) or minus (-) indicates high or low significance, respectively, with = 0.01 > P < 0.05; ++ = 0.001 > P < 0.01; = P <
0.001.
amino acid concentration of threonine is not a re- centration in the presence of a high plasma concen-
liable index of the intracellular threonine concentra- tration, and thus a decreased intracellular-to-extra-
tions. cellular gradient as well.
A similar phenomenon was observed with regard The mechanisms behind the low concentrations
to tyrosine which, after 3 months of amino acid of threonine and valine in muscle in uremic patients
treatment, showed extremely low intracellular con- are unknown. The requirements of these amino acids
Table 6. Intracellular concentrations (mmoleslliter intracellular water) of nonessential amino acids in muscle
Uremic patients on nitrogen-poor diet
I II III
.Amino
acids
-
N
Healthy subjects
---—
Mean SEM
2—3 weeks 1—2 weeks 3 months
N Mean SEM N Mean SCM N Mean SCM
Taurine 29 15.66 0.5% 10 18.51 l.482 6 19.02 2.641 6 16.65 1.402
Aspartate 12 0.900 0.119 10 2.74 0.213 6 2.88 0.2l5 6 2.29 0.244
Serine 31 1.000 0.043 10 0.924 0.084 6 0.984 0.192 6 0.894 0.148
Asparagine 14 0.481 0.029 10 0.481 0.048 6 0.434 0.082 6 0.394 0.058
Glutamine 21 19.11 0.441 10 21.56 1.46k 6 22.81 1.72 6 19.95 1.30
Glutamic acid 24 4.37 0.148 10 3.94 0.427 6 4.03 0.482 6 4.14 0.522
Proline 29 0.917 0.121 10 0.749 0.096 6 0.829 0.112 6 0.745 0.125
Citrulline 21 0.048 0.011 7 0.076 0.020 4 0.127 0.031k 6 0.148 0.04l
Glycine 30 1.49 0.091 10 2.14 0.242 6 2.21 0.242 6 1.70 0.180
Alanine 31 2.39 0.094 10 2.89 0.338k 6 2.78 0.335 6 2.57 0.206
Tyrosine 23 0.099 0.005 10 0.101 0.029 6 0.183 0.068 5 0.035 0.008
Ornitine 21 0.329 0.027 10 0.416 0.040 6 0.483 0.073 6 0.785 0.2l8
Histidine 23 0.375 0.026 10 0.410 0.061 6 0.423 0.070 6 0.560 0.076k
1-Methyl-histidine Traces 7 0.060 0.022 3 0.062 0.009 4 0.085 0.034
3-Methyl-histidine Traces 8 0.090 0.022 5 0.114 0.043 6 0.049 0.013
Carnosine 18 6.15 0.462 10 3.42 0.494--- 6 3.30 0.497—-— 6 3.80 0.428
Arginine 28 0.581 0.039 9 0.807 0.l16F 6 0.814 0.166 6 0.820 0.l60
I (nitrogen-poor diet), II (nitrogen-poor diet -f EAA for 1 to 2 weeks), and III (nitrogen-poor diet + EAA for 3 months) were
statistically compared with the normal material. The statistically significant differences between I and II, and between I and III are given
in the text. (EAA is essential amino acids plus histidine.)
Plus (+) or minus (—) indicates high or low significance, respectively, + = 0.01 > P < 0.05; ++ = 0.001 > P <: 0.01; and = P <
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